Dr. Novack Attends ARVO 2026 Annual Meeting in Denver
Dr. Gary Novack attended the 2026 ARVO Annual Meeting in Denver, continuing a tradition of more than 40 years participating in one of ophthalmology’s leading scientific conferences. During the meeting, he presented research on FDA review times and a novel investigational treatment for pterygia while connecting with colleagues and collaborators in vision science.
Dr. Novack Attends Glaucoma Research Foundation New Horizons Forum
Dr. Novack participated in the Glaucoma Research Foundation’s January 2026 New Horizons Forum, a collaborative gathering focused on emerging glaucoma therapies, diagnostics, and patient-driven innovation.
Advancing Diabetic Vision Care: Dr. Novack at the Mary Tyler Moore Vision Initiative
Ann Arbor, November 2025 — Dr. Novack attended the Mary Tyler Moore Vision Initiative Annual Meeting, collaborating with leaders in ophthalmology and vision science to reduce diabetic vision loss…
Gary Novack presents talk on new glaucoma drugs
Scientific Presentation, September 2022 — Dr. Novack presented research and perspectives on emerging glaucoma drug therapies…
Dr. Novack’s paper among top 100 glaucoma papers
The American Glaucoma Society recently sought to identify 100 articles with significant impact on the clinical care of patients with glaucoma. This was based upon citation frequency and the input of members of the Society…